Brown Advisory
KMTS

Brown Advisory’s Kestra Medical Technologies KMTS Stock Holding History

Brown Advisory’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34.4M Buy
1,723,730
+35,374
+2% +$834K 0.06% 240
2025
Q4 		$44.8M Buy
1,688,356
+428,996
+34% +$11M 0.06% 216
2025
Q3 		$29.9M Buy
1,259,360
+679,335
+117% +$12.1M 0.04% 270
2025
Q2 		$9.62M Buy
580,025
+29,607
+5% +$646K 0.01% 412
2025
Q1 		$13.7M Buy
+550,418
New +$12.6M 0.02% 357

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Brown Advisory's KMTS Position: Q1 2026 in Review

Brown Advisory increased its Kestra Medical Technologies (KMTS) stake by 2.1% in Q1 2026, buying an estimated $834K and bringing the position to 1,723,730 shares worth $34.4M. The position accounts for 0.06% of the portfolio, ranked #240.

Brown Advisory first reported a position in KMTS in Q1 2025 and has held it in 5 quarters since. The position peaked at $44.8M in Q4 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Brown Advisory held 1,723,730 shares of Kestra Medical Technologies worth $34.4M as of Q1 2026.
  • Brown Advisory bought 35,374 Kestra Medical Technologies shares in Q1 2026, an estimated $834K.
  • Kestra Medical Technologies made up 0.06% of Brown Advisory's portfolio in Q1 2026, its #240 holding.
  • Brown Advisory first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 5 quarters since.
  • Brown Advisory's Kestra Medical Technologies position peaked at $44.8M in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Brown Advisory's 13F filing for Q1 2026, filed 15 May 2026.